Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
State-of-the-Art In
Gastroenterology & Hepatology 2020
Saturday, January 25 | 8:00AM-4:00PM
South Lake Union Campus,  Campus, C Building
Orin Smith Auditorium Auditorium
850 Republic St
Seattle, WA Seattle, WA 98109

Register Now

A distinguished and experienced UW faculty panel will share this knowledge through
discussion of selected and relevant research findings with topics including the diagnosis
and treatment of GI and liver diseases, evidence-based research affecting clinical
practice, and new developments in technology and procedural innovations. In addition
to our own experienced UW Faculty, we have two national thought leaders visiting who
will provide their perspective on the implications of coagulations disorders in cirrhosis
and irritable bowel disorder.

Special Guest Speakers:Stephen Caldwell, MD​​​​​​ | Sarah Streett, MD

  • CME and MOC Accreditation
    • Sponsored by the University of Washington School of Medicine Office of Continuing Medical Education and the Division of Gastroenterology.

      The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
       
      The University of Washington School of Medicine designated this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.


      Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.​

  • Course Objectives
      1. Discuss the most relevant research findings presented at the Liver Meeting 2019 and Digestive Disease Week 2019
      2. Define recent developments in the diagnosis and treatment of GI and liver diseases
      3. Discuss the state-of-the-art of colorectal cancer screening
      4. Define new developments in gastrointestinal endoscoph
      5. Discuss evidence-based research that affects the practice of clinical gastroenterology and hepatology
      6. Apply evidence-based approach to construct new treatment strategies

  • Target Audience
    • This course is specifically designed for gastroenterologists, hepatologists, surgeons, GI transplant hepatology nurses, and other health care providers who treat patients with digestive diseases, and who are interested in keeping abreast of the latest advances in research and state-of-the-art clinical practices in the fields of gastroenterology and hepatology.

  • Course Agenda: Morning Session
    • ​07:30AM-08:30AM REGISTRATION


      SESSION 1 | 08:30AM-10:20AM

      Changes in Liver Transplant Allocation: Important Updates for Your Patients
      Speaker: Scott Biggins, MD, MAS
      Associate Professorr & Director, Liver Care Line

      Cardiopulmonary Disease and the Liver
      Speaker: Renuka Bhattacharya, MD
      Clinical Associate Professor & Clinical Chief of Hepatology
      Director, Transplant Hepatology Fellowship Program
       
      Coagulation Issues in Liver Diease
      Speaker: Stephen Caldwell, MD
      Director of Hepatology
      University of Virginia
       
      Q&A SESSION


       
      10:20AM-10:40AM - BREAK


       
      SESSION 2 | 10:40AM-12:00PM

      Diet and the Microbiome as Potential Treatments for Non-Alcoholic Fatty Liver Disease

      Speaker: William DePaolo, PhD
      Associate Professor & Director, Center for Microbiome Sciences & Therapeutics (CMiST)
       
      Cholangiocarcinoma: Approach to Diagnostic Challenges and Liver Transplant at the University of Washington
      Clinical Associate Professor
      Associate Professor
       
      Q&A SESSION

  • Course Agenda: Afternoon Session
    • 12:00PM-01:00PM LUNCH & EXHIBITORS


      SESSION 3 | 01:00PM-02:20PM

      Neuromodulators in GI Disorders
      Speaker: Gorav Kalra, MD
      Clinical Assistant Professor

      Therapies in IBD
      Speaker: Sarah Streett, MD
      Clinical Director, Inflammatory Bowel Disease
      Stanford University

      Q&A SESSION


      02:20PM-02:40PM - BREAK


      SESSION 4 | 02:40PM-04:40PM


      Colorectal Cancer Under 50: Current Trends and Future Directions
      Speaker: Rachel Issaka, MD
      Assistant Professor & Assistant Member, Fred Hutchinson Cancer Research Center

      Complex Polypectomies
      Speaker: Adam Templeton, MD
      Clinical Associate Professor

      Selected Topics in Preventative Care for IBD
      Speaker: Jason Harper, MD
      Clinical Assistant Professor & Director, Harborview Inflammatory Bowel Disease Program

      Q&A SESSION


      04:40PM - ADJOURN

  • Course Sponsors & Exhibitors
    • The University of Washington Division of Gastroenterology would like to thank the following sponsors and exhibitors for their generous support:








       

©2016-2018 University of Washington Division of Gastroenterology
1959 NE Pacific St., Box 356424, Seattle, WA 98195-6424
Contact Us | Privacy | Terms | Copyright & Disclaimer